2D·

What's going on again today?

4
11 Comentários

imagem de perfil
Almost +87% on a monthly basis, +125% ytd, +514% on a 1Y basis... With such a steep rise, there are also steep falls
25
imagem de perfil
Shares of Hims & Hers Health, Inc (NYSE: NYSE:HIMS) plunged 18% after the U.S. Food and Drug Administration (FDA) announced that the shortage of Novo Nordisk (NYSE:NVO) A/S' weight-loss drug had been overcome.

This regulatory decision is expected to have a significant impact on the availability and sale of cheaper, compounded versions of the drug, which were previously offered by telemedicine companies such as Hims & Hers Health.
2
imagem de perfil
Ceo sold some shares
With $HIMS there is always this kind of ups and downs
1
Normal volatility for the share
1
imagem de perfil
imagem de perfil
Shortage ended, see my post
1
imagem de perfil
@Aktienfoxx I have never heard of shortage. What exactly is that?
1
imagem de perfil
Sell again quickly🚀😋
imagem de perfil
@Mark777 Yes, thanks for the tip......
Enjoy the ride backwarts 😀😀😀😀
imagem de perfil
There was probably some profit-taking. But I am convinced that this will soon be over. The share is still being shorted like crazy.
Participar na conversa